Valérie Boudreau1, Adèle Coriati2, Imane Hammana3, Sophie Ziai4, Katherine Desjardins5, Yves Berthiaume6, Rémi Rabasa-Lhoret7. 1. Institut de Recherches Cliniques de Montréal, Montréal, Québec H2W 1R7, Canada; Department of Nutrition, Université de Montréal, Montréal, Québec, Canada. Electronic address: valerie.boudreau@ircm.qc.ca. 2. Institut de Recherches Cliniques de Montréal, Montréal, Québec H2W 1R7, Canada; Department of Nutrition, Université de Montréal, Montréal, Québec, Canada. Electronic address: adele.coriati@ircm.qc.ca. 3. Institut de Recherches Cliniques de Montréal, Montréal, Québec H2W 1R7, Canada; Department of Nutrition, Université de Montréal, Montréal, Québec, Canada. Electronic address: imane.hammana.chum@ssss.gouv.qc.ca. 4. Institut de Recherches Cliniques de Montréal, Montréal, Québec H2W 1R7, Canada; Department of Nutrition, Université de Montréal, Montréal, Québec, Canada. Electronic address: sophie.1.ziai@gmail.com. 5. Institut de Recherches Cliniques de Montréal, Montréal, Québec H2W 1R7, Canada; Department of Nutrition, Université de Montréal, Montréal, Québec, Canada. Electronic address: katherine.desjardins@ircm.qc.ca. 6. Institut de Recherches Cliniques de Montréal, Montréal, Québec H2W 1R7, Canada; Cystic Fibrosis Clinic, Centre Hospitalier de l'Université de Montréal (CHUM)-Hôtel-Dieu, Montréal, Québec, Canada; Department of Medicine, Université de Montréal, Montréal, Québec, Canada. Electronic address: yves.berthiaume@ircm.qc.ca. 7. Institut de Recherches Cliniques de Montréal, Montréal, Québec H2W 1R7, Canada; Department of Nutrition, Université de Montréal, Montréal, Québec, Canada; Cystic Fibrosis Clinic, Centre Hospitalier de l'Université de Montréal (CHUM)-Hôtel-Dieu, Montréal, Québec, Canada; Department of Medicine, Université de Montréal, Montréal, Québec, Canada. Electronic address: remi.rabasa-lhoret@ircm.qc.ca.
Abstract
BACKGROUND: Reduced insulin secretion is a key factor to explain high prevalence of glucose intolerance in patients with cystic fibrosis (CF). However, the role of insulin sensitivity remains unclear. The aim of this study is to investigate the association of insulin secretion and sensitivity with the evolution of glucose tolerance. METHODS: A total of 152 patients without known diabetes from the Montreal CF cohort underwent two 2-h oral glucose tolerance tests (OGTT) at baseline and again after 21.2±5.5months. Pulmonary function and anthropometric measurements were also collected at each visit. At both visits, based on their OGTT results, patients were categorized in glucose tolerance groups (normal glucose tolerance, impaired glucose tolerance or CF-related diabetes) and stratified in 3 groups according to the variation of their glucose tolerance: stable, improved or deteriorated. RESULTS: At baseline, patients in the deteriorated group had a better sensitivity to insulin than those in the improved group (P=0.029). At follow-up glucose tolerance remained stable in 55.3%, improved in 14.5% and deteriorated in 30.3% of patients. During follow-up, insulin secretion remained stable in all 3 groups. While insulin sensitivity remained stable in patients without changes in glucose tolerance it worsened in patients who deteriorated glucose tolerance (P<0.001) and improved in patients who improved their glucose tolerance (P=0.003). CONCLUSION: In a context of significantly reduced insulin secretion, variations of insulin sensitivity are associated with variations of glucose tolerance in adult patients with CF. Copyright Â
BACKGROUND: Reduced insulin secretion is a key factor to explain high prevalence of glucose intolerance in patients with cystic fibrosis (CF). However, the role of insulin sensitivity remains unclear. The aim of this study is to investigate the association of insulin secretion and sensitivity with the evolution of glucose tolerance. METHODS: A total of 152 patients without known diabetes from the Montreal CF cohort underwent two 2-h oral glucose tolerance tests (OGTT) at baseline and again after 21.2±5.5months. Pulmonary function and anthropometric measurements were also collected at each visit. At both visits, based on their OGTT results, patients were categorized in glucose tolerance groups (normal glucose tolerance, impaired glucose tolerance or CF-related diabetes) and stratified in 3 groups according to the variation of their glucose tolerance: stable, improved or deteriorated. RESULTS: At baseline, patients in the deteriorated group had a better sensitivity to insulin than those in the improved group (P=0.029). At follow-up glucose tolerance remained stable in 55.3%, improved in 14.5% and deteriorated in 30.3% of patients. During follow-up, insulin secretion remained stable in all 3 groups. While insulin sensitivity remained stable in patients without changes in glucose tolerance it worsened in patients who deteriorated glucose tolerance (P<0.001) and improved in patients who improved their glucose tolerance (P=0.003). CONCLUSION: In a context of significantly reduced insulin secretion, variations of insulin sensitivity are associated with variations of glucose tolerance in adult patients with CF. Copyright Â
Authors: Yu-Chung Lin; Katherine Keenan; Jiafen Gong; Naim Panjwani; Julie Avolio; Fan Lin; Damien Adam; Paula Barrett; Stéphanie Bégin; Yves Berthiaume; Lara Bilodeau; Candice Bjornson; Janna Brusky; Caroline Burgess; Mark Chilvers; Raquel Consunji-Araneta; Guillaume Côté-Maurais; Andrea Dale; Christine Donnelly; Lori Fairservice; Katie Griffin; Natalie Henderson; Angela Hillaby; Daniel Hughes; Shaikh Iqbal; Jennifer Itterman; Mary Jackson; Emma Karlsen; Lorna Kosteniuk; Lynda Lazosky; Winnie Leung; Valerie Levesque; Émilie Maille; Dimas Mateos-Corral; Vanessa McMahon; Mays Merjaneh; Nancy Morrison; Michael Parkins; Jennifer Pike; April Price; Bradley S Quon; Joe Reisman; Clare Smith; Mary Jane Smith; Nathalie Vadeboncoeur; Danny Veniott; Terry Viczko; Pearce Wilcox; Richard van Wylick; Garry Cutting; Elizabeth Tullis; Felix Ratjen; Johanna M Rommens; Lei Sun; Melinda Solomon; Anne L Stephenson; Emmanuelle Brochiero; Scott Blackman; Harriet Corvol; Lisa J Strug Journal: Genet Med Date: 2021-01-26 Impact factor: 8.822
Authors: Karolinne Souza Monteiro; Matheus de Paiva Azevedo; Lucas Menescal Jales; Fernanda Elizabeth Pereira da Silva; Ricardo Fernando Arrais; Karla Morganna Pereira Pinto de Mendonça Journal: Trials Date: 2019-12-26 Impact factor: 2.279